Atara Biotherapeutics (ATRA) came out with a quarterly loss of $2.93 per share ... estimates three times over the last four quarters. The sustainability of the stock's immediate price movement based ...

How to use Atara Biotherapeutics Inc. ATRA as a Forecasting Tool ...

Analysts are estimating that Atara Biotherapeutics will report an earnings per share (EPS) of $-1.93. Atara Biotherapeutics ...

The Reverse Stock Split will become effective at 12:01 ... June 05, 2024--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein ...

Atara Biotherapeutics (NASDAQ:ATRA – Get Free Report ... an “outperform” rating and lowered their price target for the stock from $25.00 to $18.00 in a report on Friday, August 16th.

Short interest in Atara Biotherapeutics Inc (NASDAQ:ATRA) increased during the last ... betting on the decline of Atara Biotherapeutics's stock. Short interest data is updated every two weeks.

Yatra Online, Inc. (YTRA) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to loss of $0.02 per share a year ago. These figures ...

Atara Biotherapeutics (ATRA) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings ...